The FDA has approved the first new drug to treat lupus since 1955, reports the New York Times , giving sufferers sanctioned options beyond aspirin, a malaria drug, corticosteroids, and a handful of other drugs used off-label with minimal success. Benlysta will be marketed by GlaxoSmithKline at an estimated per-patient cost…
Read the original here:
FDA OKs 1st Lupus Drug in 50 Years
The FDA has approved the first new drug to treat lupus since 1955, reports the New York Times , giving sufferers sanctioned options beyond aspirin, a malaria drug, corticosteroids, and a handful of other drugs used off-label with minimal success. Benlysta will be marketed by GlaxoSmithKline at an estimated per-patient cost…
Go here to see the original:
FDA OKs 1st Lupus Drug in 50 Years
The FDA has approved the first new drug to treat lupus since 1955, reports the New York Times , giving sufferers sanctioned options beyond aspirin, a malaria drug, corticosteroids, and a handful of other drugs used off-label with minimal success. Benlysta will be marketed by GlaxoSmithKline at an estimated per-patient cost…
Excerpt from:
FDA OKs 1st Lupus Drug in 50 Years
The FDA has approved the first new drug to treat lupus since 1955, reports the New York Times , giving sufferers sanctioned options beyond aspirin, a malaria drug, corticosteroids, and a handful of other drugs used off-label with minimal success. Benlysta will be marketed by GlaxoSmithKline at an estimated per-patient cost…
Read the original here:
FDA OKs 1st Lupus Drug in 50 Years
The FDA has approved the first new drug to treat lupus since 1955, reports the New York Times , giving sufferers sanctioned options beyond aspirin, a malaria drug, corticosteroids, and a handful of other drugs used off-label with minimal success. Benlysta will be marketed by GlaxoSmithKline at an estimated per-patient cost…
Read more from the original source:
FDA OKs 1st Lupus Drug in 50 Years